They are funded through until at least mid next year by which time they will have results of three phase 2 trials. The most important milestone this year is the interim data release for SNT 5505 in myelofibrosis - and a presentation at ASH in December. Spec buy and hold until then in my opinion.
- Forums
- ASX - By Stock
- SNT
- Ann: Phase 2 Trial Reaches 50% Recruitment
Ann: Phase 2 Trial Reaches 50% Recruitment, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.2¢ |
Change
0.005(10.6%) |
Mkt cap ! $71.40M |
Open | High | Low | Value | Volume |
4.8¢ | 5.4¢ | 4.6¢ | $176.7K | 3.467M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 225623 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 120442 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 225623 | 0.051 |
2 | 309996 | 0.050 |
1 | 19998 | 0.049 |
3 | 121996 | 0.048 |
1 | 120000 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 104220 | 1 |
0.054 | 53415 | 2 |
0.055 | 115000 | 2 |
0.057 | 257052 | 2 |
0.060 | 117667 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |